We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Synthetic Biologics Inc | AMEX:SYN | AMEX | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.02 | 0 | 00:00:00 |
Hot Features
Premium
RNS Number:0196L
Synstar PLC
13 May 2003
SYNSTAR PLC ("the Company")
13 May 2003
HOLDING IN COMPANY
The Company was notified on 12 May 2003 that Aberforth Partners ("Aberforth")
has a notifiable interest in 18,217,295 ordinary shares of 1p each in the
Company ("Shares") representing approximately 11.21% of the Company's issued
ordinary share capital. The interest arises as a result of discretionary
management powers which Aberforth can exercise over their clients' funds and is
not beneficial.
The Shares are, or will be, registered as follows:
Clydesdale Bank (Head Office) Nominees Ltd a/c ABERFIT1 6,321,200
Clydesdale Bank (Head Office) Nominees Ltd a/c ABERFIT2 3,396,700
Clydesdale Bank (Head Office) Nominees Ltd a/c ABERFUT1 6,697,495
State Street Nominees Ltd a/c JD59 1,801,900
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLNKNKBDBKDNPD
1 Year Synthetic Biologics Chart |
1 Month Synthetic Biologics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
